New gene-based approaches for an AIDS vaccine (Q35159094)

6 August 2017

1 reference

title

New gene-based approaches for an AIDS vaccine (English)

1 reference

6 August 2017

1

Anne-Laure Puaux

1 reference

6 August 2017

Marie-Louise Michel

2

1 reference

6 August 2017

publication date

1 October 2003

1 reference

Comparative Immunology, Microbiology & Infectious Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

26

1 reference

6 August 2017

issue

5-6

1 reference

6 August 2017

page(s)

357-372

1 reference

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Titration and characterization of two rhesus-derived SIVmac challenge stocks

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Immune responses following simian/human immunodeficiency virus (SHIV) challenge of rhesus macaques after human immunodeficiency virus (HIV)-1 third variable domain (V3) loop-based genetic immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

CpG oligodeoxynucleotides as vaccine adjuvants in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and protease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

DNA-based immunization against the envelope proteins of the hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Expansion of HBV-specific memory CTL primed by dual HIV/HBV genetic immunization during SHIV primary infection in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900020-1

7 January 2021

10.1016/S0147-9571(03)00020-1

Identifiers

DOI

1 reference

6 August 2017

1 reference